C

CASI Pharmaceuticals Inc
NASDAQ:CASI

Watchlist Manager
CASI Pharmaceuticals Inc
NASDAQ:CASI
Watchlist
Price: 5.55 USD -0.89% Market Closed
Market Cap: 74.4m USD
Have any thoughts about
CASI Pharmaceuticals Inc?
Write Note

CASI Pharmaceuticals Inc
Total Other Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

CASI Pharmaceuticals Inc
Total Other Income Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Total Other Income Analysis
Latest Figures & CAGR of Competitors

Company Total Other Income CAGR 3Y CAGR 5Y CAGR 10Y
C
CASI Pharmaceuticals Inc
NASDAQ:CASI
Total Other Income
$764k
CAGR 3-Years
112%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Total Other Income
-$4.6B
CAGR 3-Years
12%
CAGR 5-Years
-16%
CAGR 10-Years
N/A
Gilead Sciences Inc
NASDAQ:GILD
Total Other Income
$302m
CAGR 3-Years
76%
CAGR 5-Years
-14%
CAGR 10-Years
N/A
Amgen Inc
NASDAQ:AMGN
Total Other Income
$578m
CAGR 3-Years
81%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Total Other Income
-$65.2m
CAGR 3-Years
N/A
CAGR 5-Years
-25%
CAGR 10-Years
N/A
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Total Other Income
$6m
CAGR 3-Years
-49%
CAGR 5-Years
-35%
CAGR 10-Years
8%

See Also

What is CASI Pharmaceuticals Inc's Total Other Income?
Total Other Income
764k USD

Based on the financial report for Dec 31, 2023, CASI Pharmaceuticals Inc's Total Other Income amounts to 764k USD.

What is CASI Pharmaceuticals Inc's Total Other Income growth rate?
Total Other Income CAGR 3Y
112%

Over the last year, the Total Other Income growth was 1 810%. The average annual Total Other Income growth rates for CASI Pharmaceuticals Inc have been 112% over the past three years .

Back to Top